Janus Henderson Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2M | Hold |
7,900
| – | – | ﹤0.01% | 1299 |
|
|
2025
Q4 | $2.39M | Hold |
7,900
| – | – | ﹤0.01% | 1251 |
|
|
2025
Q3 | $2.21M | Hold |
7,900
| – | – | ﹤0.01% | 1288 |
|
|
2025
Q2 | $1.91M | Buy |
7,900
+6,696
| +556% | +$1.58M | ﹤0.01% | 1306 |
|
|
2025
Q1 | $293K | Hold |
1,204
| – | – | ﹤0.01% | 2214 |
|
|
2024
Q4 | $396K | Hold |
1,204
| – | – | ﹤0.01% | 2147 |
|
|
2024
Q3 | $403K | Sell |
1,204
-1,443
| -55% | -$458K | ﹤0.01% | 2135 |
|
|
2024
Q2 | $723K | Sell |
2,647
-109
| -4% | -$31.7K | ﹤0.01% | 1797 |
|
|
2024
Q1 | $952K | Buy |
2,756
+3
| +0.1% | +$987 | ﹤0.01% | 1670 |
|
|
2023
Q4 | $890K | Sell |
2,753
-16
| -0.6% | -$5.01K | ﹤0.01% | 1684 |
|
|
2023
Q3 | $993K | Sell |
2,769
-143
| -5% | -$55.2K | ﹤0.01% | 1560 |
|
|
2023
Q2 | $1.1M | Sell |
2,912
-255
| -8% | -$104K | ﹤0.01% | 1560 |
|
|
2023
Q1 | $1.52M | Sell |
3,167
-14,925
| -82% | -$6.99M | ﹤0.01% | 1413 |
|
|
2022
Q4 | $7.61M | Sell |
18,092
-8,248
| -31% | -$3.33M | 0.01% | 775 |
|
|
2022
Q3 | $11M | Buy |
26,340
+14,208
| +117% | +$7.08M | ﹤0.01% | 805 |
|
|
2022
Q2 | $6M | Sell |
12,132
-36,193
| -75% | -$18.8M | ﹤0.01% | 803 |
|
|
2022
Q1 | $27.2M | Sell |
48,325
-21,323
| -31% | -$12.9M | 0.01% | 677 |
|
|
2021
Q4 | $52.6M | Sell |
69,648
-55,859
| -45% | -$41.8M | 0.02% | 531 |
|
|
2021
Q3 | $93.6M | Sell |
125,507
-24,950
| -17% | -$18.7M | 0.04% | 370 |
|
|
2021
Q2 | $96.9M | Buy |
150,457
+58,933
| +64% | +$35.9M | 0.04% | 373 |
|
|
2021
Q1 | $52.3M | Buy |
91,524
+34,635
| +61% | +$20.5M | 0.02% | 538 |
|
|
2020
Q4 | $33.2M | Buy |
56,889
+12,587
| +28% | +$7.17M | 0.02% | 638 |
|
|
2020
Q3 | $22.8M | Buy |
44,302
+13,023
| +42% | +$6.6M | 0.01% | 680 |
|
|
2020
Q2 | $14.1M | Buy |
31,279
+30,599
| +4,500% | +$13.5M | 0.01% | 763 |
|
|
2020
Q1 | $238K | Buy |
+680
| New | +$250K | ﹤0.01% | 1246 |
|
|
2019
Q2 | – | Sell |
-866
| Closed | -$265K | – | 1373 |
|
|
2019
Q1 | $265K | Sell |
866
-483
| -36% | -$130K | ﹤0.01% | 1304 |
|
|
2018
Q4 | $313K | Buy |
+1,349
| New | +$362K | ﹤0.01% | 1268 |
|
|
2018
Q3 | – | Sell |
-3,200
| Closed | -$923K | – | 1449 |
|
|
2018
Q2 | $923K | Sell |
3,200
-14,110
| -82% | -$3.9M | ﹤0.01% | 1235 |
|
|
2018
Q1 | $4.33M | Sell |
17,310
-12,600
| -42% | -$3.21M | ﹤0.01% | 1038 |
|
|
2017
Q4 | $7.14M | Sell |
29,910
-6,400
| -18% | -$1.55M | ﹤0.01% | 927 |
|
|
2017
Q3 | $8.07M | Buy |
36,310
+2,800
| +8% | +$630K | 0.01% | 893 |
|
|
2017
Q2 | $7.58M | Buy |
+33,510
| New | +$7.3M | 0.01% | 921 |
|
Other funds holding BIO
VCM
VPM
AI
Janus Henderson Group's BIO Position: Q1 2026 in Review
Janus Henderson Group held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2026 at 7,900 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1299.
Janus Henderson Group first reported a position in BIO in Q2 2017 and has held it in 32 quarters since. The position peaked at $96.9M in Q2 2021. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Janus Henderson Group held 7,900 shares of Bio-Rad Laboratories Class A worth $2.2M as of Q1 2026.
- Janus Henderson Group left its Bio-Rad Laboratories Class A share count unchanged in Q1 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1299 holding.
- Janus Henderson Group first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and has held it in 32 quarters since.
- Janus Henderson Group's Bio-Rad Laboratories Class A position peaked at $96.9M in Q2 2021.
- 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.